CVS Group plc (LON:CVSG - Get Free Report)'s share price crossed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 1,012.09 ($13.66) and traded as high as GBX 1,290 ($17.42). CVS Group shares last traded at GBX 1,247.64 ($16.84), with a volume of 220,513 shares.
CVS Group Trading Up 0.3%
The business has a 50 day simple moving average of GBX 1,148.87 and a two-hundred day simple moving average of GBX 1,012.09. The company has a current ratio of 1.09, a quick ratio of 0.90 and a debt-to-equity ratio of 110.52. The company has a market cap of £921.71 million, a PE ratio of 44.52, a price-to-earnings-growth ratio of 1.77 and a beta of 1.02.
Insider Activity at CVS Group
In related news, insider David Wilton purchased 1,000 shares of the firm's stock in a transaction on Monday, June 2nd. The shares were bought at an average price of GBX 1,248 ($16.85) per share, for a total transaction of £12,480 ($16,848.93). Also, insider Richard Gray sold 305 shares of the business's stock in a transaction on Wednesday, March 26th. The shares were sold at an average price of GBX 1,007 ($13.60), for a total transaction of £3,071.35 ($4,146.55). Insiders own 5.83% of the company's stock.
CVS Group Company Profile
(
Get Free Report)
CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. It operates in animal veterinary practices and complementary veterinary diagnostic businesses.
See Also
Before you consider CVS Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Group wasn't on the list.
While CVS Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
